Active, not recruitingPhase 2NCT02756897

Venetoclax and Ibrutinib in Treating Patients With Chronic or Small Lymphocytic Leukemia

Studying B-cell chronic lymphocytic leukemia

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
M.D. Anderson Cancer Center
Principal Investigator
Nitin Jain
M.D. Anderson Cancer Center
Intervention
Ibrutinib(drug)
Enrollment
234 enrolled
Eligibility
18 years · All sexes
Timeline
2016 – 2027

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02756897 on ClinicalTrials.gov

Other trials for B-cell chronic lymphocytic leukemia

Additional recruiting or active studies for the same condition.

See all trials for B-cell chronic lymphocytic leukemia →

← Back to all trials